Tak Wah Mak

Tak Wah Mak

Tak Wah Mak, is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has worked in a variety of areas including biochemistry, immunology, and cancer genetics.

From *.wikipedia.org,
General Info
.
Male
Date of Birth
October 4th, 1946
Age
78
Birth Place
People's Republic of China, Guangdong
Star Sign
Libra
Social Networks , Links
Interest
Loading Chart...
Lists
    index: 1x 0.064219951629639s
fmsppl-page-output: 1x 0.060698986053467s
t_/pages/fms-person-json: 1x 0.060662984848022s
t_/blocks/person-card-json: 1x 0.03429102897644s
t_/common/header: 1x 0.025344848632812s
headline: 7x 0.017813920974731s
t_/common/head: 1x 0.0088608264923096s
head-facts: 1x 0.008781909942627s
router_page: 1x 0.0026180744171143s
t_/common/footer: 1x 0.00073909759521484s
t_/common/searcher-result: 1x 2.598762512207E-5s
----- END OF DUMP (2024-11-21 17:10:11)  -----